Medicinal – Page 84

Inonotus hispidus Protects against Hyperlipidemia by Inhibiting Oxidative Stress and Inflammation through Nrf2/NF-κB Signaling in High Fat Diet Fed Mice

mycolabadmin

Inonotus hispidus is an edible mushroom that may help treat obesity and high cholesterol by reducing fat levels and inflammation in the body. In mice fed a high-fat diet, the mushroom improved cholesterol profiles, reduced liver damage, and promoted beneficial gut bacteria. The beneficial effects appear to work through activating the body’s natural antioxidant defenses and reducing inflammation-causing proteins.

Butyrate ameliorates quinolinic acid–induced cognitive decline in obesity models

mycolabadmin

This research shows that overweight and obese individuals have higher levels of a toxic compound called quinolinic acid in their bodies, which is linked to memory problems and brain shrinkage. The good news is that butyrate, a substance naturally produced by gut bacteria when we eat fiber, can protect against these harmful effects. Butyrate works by activating genes that produce brain-derived neurotrophic factor (BDNF), a protein essential for brain health and memory formation. The study suggests that increasing butyrate through diet or supplements could help prevent cognitive decline associated with obesity.

Multi-omics reveals novel forage advantages of Potentilla anserina Linnaeus in high-salt habitats

mycolabadmin

Potentilla anserina, a traditional Tibetan plant, can be grown as animal feed on salty, unused land. Researchers found that when the plant is fermented as silage, it becomes more nutritious and develops beneficial microbes that help it resist salt and drought. This makes it a promising sustainable feed option for livestock raised in areas with saline soils.

First reported Canadian case of Trichophyton mentagrophytes genotype VII infection among men who have sex with men (MSM)

mycolabadmin

A Canadian man contracted a rare fungal skin infection caused by Trichophyton mentagrophytes genotype VII during a trip to Mexico, likely through sexual contact. The infection presented as deep, painful lesions in the genital area that didn’t respond to typical treatments and required 10 weeks of oral and topical antifungal medication to cure. This is the first confirmed case in Canada and highlights the importance of doctors being aware of sexually transmitted fungal infections, especially in patients with unusual rashes that don’t improve with standard treatments.

Research on the Action and Mechanism of Pharmacological Components of Omphalia lapidescens

mycolabadmin

Omphalia lapidescens, a medicinal fungus used in traditional Chinese medicine, contains multiple bioactive compounds with promising health benefits. These compounds can fight parasitic infections, inhibit cancer cell growth, reduce inflammation, and provide antioxidant protection. While clinical use shows benefits especially for gastric cancer when combined with chemotherapy, more research is needed to understand how these compounds work and to improve cultivation and production methods.

Clinical experience of primary subcutaneous mycoses in Shanghai: a retrospective analysis

mycolabadmin

Researchers in Shanghai studied 33 patients with deep skin fungal infections that had become increasingly common in the area. They identified 13 different fungal species causing these infections, most commonly Candida parapsilosis, Trichophyton rubrum, and Sporothrix schenckii. Patients were treated with antifungal medications tailored to the specific fungus and its drug sensitivity, with most patients recovering completely, though some experienced relapses, emphasizing the importance of long-term follow-up care.

Miniaturized high-throughput conversion of fungal strain collections into chemically characterized extract libraries for antimicrobial discovery

mycolabadmin

Scientists developed a fast, automated method called FLECS-96 to screen hundreds of fungal species for antimicrobial compounds in a small 96-well plate format. The method combines fungal culture, chemical extraction, and analysis to identify promising candidates against resistant bacteria like Staphylococcus aureus. The team successfully identified two bioactive compounds from the fungi tested. This innovation could significantly speed up the discovery of new antibiotics to combat antibiotic-resistant infections.

Complete genome sequence analysis of Boeremia exigua, a fungal pathogen causing leaf spot disease of Panax notoginseng

mycolabadmin

Panax notoginseng, a valuable traditional Chinese medicinal plant, has been affected by a fungal leaf spot disease caused by Boeremia exigua. Researchers sequenced the complete genome of this fungal pathogen for the first time, discovering important genes responsible for its ability to infect plants, including enzymes that break down plant cell walls and proteins that help it evade plant defenses. This genetic information provides a foundation for developing better strategies to protect these valuable medicinal plants from disease.

Harnessing Walnut-Based Zinc Oxide Nanoparticles: A Sustainable Approach to Combat the Disease Complex of Meloidogyne arenaria and Macrophomina phaseolina in Cowpea

mycolabadmin

Researchers created tiny particles made from walnut leaves and zinc oxide that can fight harmful plant diseases caused by root-knot nematodes and fungal infections in cowpea plants. When applied to diseased plants, these natural nanoparticles significantly reduced pest populations, improved plant growth and health, and helped plants recover from stress without harming beneficial bacteria in the soil. This green technology offers farmers an environmentally friendly alternative to traditional chemical pesticides.

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methods

mycolabadmin

Researchers compared three different laboratory methods for testing how well antifungal drugs work against common yeast infections. They tested 22 different yeast strains including Candida species using CLSI, EUCAST, and Sensititre YeastOne methods. The methods showed strong agreement overall, but some newer antifungal drugs like ibrexafungerp showed more variation between methods. The findings suggest these methods are reliable for guiding treatment decisions, but further standardization is needed for newer drugs.

Research Topic: Medicinal